Takaomi Saido on Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain.
COMMENT The work further supports the applicability of NSAIDs to prevention and therapy of AD. 0 saido